Neoplasms, Hematologic Completed Phase 2 Trials for Methotrexate (DB00563)

Also known as: Hematologic Neoplasm / Hematologic Neoplasms

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01790568Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell TransplantPrevention